Neogenomics Inc Revenue Growth Rates (NEO), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Neogenomics Inc   (NASDAQ: NEO)
    Sector • Technology    Industry • IT Infrastructure
   Industry • IT Infrastructure
   Sector • Technology
 

NEO's Revenue Growth by Quarter and Year

Neogenomics Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NEO Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 201.66
1st Quarter March 185.86
FY 387.52

NEOs Annual Revenue
Neogenomics Inc 's Revenue in the fiscal year 2025 $ 727.29 millions
Neogenomics Inc 's Revenue in the fiscal year 2024 $ 660.10 millions
Neogenomics Inc 's Revenue in the fiscal year 2023 $ 591.60 millions
Neogenomics Inc 's Revenue in the fiscal year 2022 $ 509.73 millions
Neogenomics Inc 's Revenue in the fiscal year 2021 $ 484.33 millions




NEO Revenue second quarter 2026 Y/Y Growth Comment
Neogenomics Inc reported Revenue increase of 11.25% year on year in the second quarter 2026, to $ 201.66 millions, this is lower than Neogenomics Inc 's recent average Revenue improvement of 24.69%.

Looking into second quarter 2026 results within IT Infrastructure industry 34 other companies have achieved higher Revenue growth. While Neogenomics Inc ' s Revenue growth of 11.25% ranks overall at the positon no. 2438 in the second quarter 2026.


NEO Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 10.44 % 10.94 % 12.59 %
3rd Quarter September - 12.33 % 10.29 % 17.49 %
2nd Quarter June 11.25 % 10.2 % 11.98 % 17.45 %
1st Quarter March 11.13 % 7.58 % 13.3 % 17.11 %
FY   - 10.18 % 11.58 % -

Financial Statements
Neogenomics Inc 's second quarter 2026 Revenue $ 201.66 millions NEO's Income Statement
Neogenomics Inc 's second quarter 2025 Revenue $ 181.26 millions Quarterly NEO's Income Statement


NEO Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 2.08 % 3.82 % 3.22 %
3rd Quarter September - 3.41 % 1.45 % 3.01 %
2nd Quarter June 8.5 % 8.38 % 5.8 % 7.05 %
1st Quarter March -2.86 % -3.47 % -0.45 % -1.07 %
FY (Year on Year)   - 10.18 % 11.58 % -


Back to NEO Growth rate Comparisons >> Back to NEO Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
IT Infrastructure Industry #35
Technology Sector #394
Overall #2438

Revenue Y/Y Growth Statistics
High Average Low
144.57 % 24.69 % 0.13 %
(Dec 31 2016)   (Jun 30 2022)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
IT Infrastructure Industry #35
Technology Sector #394
Overall #2438
Revenue Y/Y Growth Statistics
High Average Low
144.57 % 24.69 % 0.13 %
(Dec 31 2016)   (Jun 30 2022)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Neogenomics Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
118.86 % 6.15 % -17.97 %
(Mar 31 2016)  


NEO's II. Quarter Q/Q Revenue Comment
Neogenomics Inc achieved in the II. Quarter 2026 above company average sequential Revenue increase of 8.5%, to $ 201.66 millions, from $185.86 millions in the first quarter.
NEO is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within IT Infrastructure industry 14 other companies have achieved higher Revenue quarter on quarter growth. While Neogenomics Inc 's Revenue growth quarter on quarter, overall rank is 898.


Revenue Q/Q Growth Company Ranking
Within: No.
IT Infrastructure Industry #15
Technology Sector #125
Overall #898
Revenue Q/Q Growth Company Ranking
Within: No.
IT Infrastructure Industry #15
Technology Sector #125
Overall #898
Revenue Q/Q Growth Statistics
High Average Low
118.86 % 6.15 % -17.97 %
(Mar 31 2016)  


NEO's II. Quarter Q/Q Revenue Comment
Neogenomics Inc achieved in the II. Quarter 2026 above company average sequential Revenue increase of 8.5%, to $ 201.66 millions, from $185.86 millions in the first quarter.
NEO is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within IT Infrastructure industry 14 other companies have achieved higher Revenue quarter on quarter growth. While Neogenomics Inc 's Revenue growth quarter on quarter, overall rank is 898.


Neogenomics Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 766.31 $ 745.91 $ 727.29 $ 709.21 $ 688.64
Y / Y Revenue Growth (TTM) 11.28 % 11.02 % 10.18 % 10.29 % 9.75 %
Year on Year Revenue Growth Overall Ranking # 1413 # 1677 # 1338 # 1325 # 1249
Seqeuential Revenue Change (TTM) 2.73 % 2.56 % 2.55 % 2.99 % 2.5 %
Seq. Revenue Growth (TTM) Overall Ranking # 1413 # 1677 # 1338 # 1325 # 1249


Cumulative Revenue growth Comment
Although Neogenomics Inc 's Annual Revenue growth year on year were below company's average 24.45% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 11.28% year on year, from 11.02% in Mar 31 2026.

In the Technology sector 273 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1413, from total ranking in previous quarter at 1677.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
IT Infrastructure Industry # 23
Technology Sector # 274
Overall # 1529

Revenue TTM Y/Y Growth Statistics
High Average Low
144.57 %
 24.45 %
0.13 %
(Dec 31 2016)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 34
Sector # 382
S&P 500 # 2363
Cumulative Revenue growth Comment
Although Neogenomics Inc 's Annual Revenue growth year on year were below company's average 24.45% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 11.28% year on year, from 11.02% in Mar 31 2026.

In the Technology sector 273 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1413, from total ranking in previous quarter at 1677.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
IT Infrastructure Industry # 23
Technology Sector # 274
Overall # 1529

Revenue TTM Y/Y Growth Statistics
High Average Low
144.57 %
24.45 %
0.13 %
(Dec 31 2016)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 34
Sector # 382
S&P 500 # 2363




Other Revenue Growth
IT Infrastructure Industry Revenue Growth Trends and Statistics
Technology Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
NEO's Revenue Growth Ratio versus IT Infrastructure Industry, Technology Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue increase for the quarter ending Jun 30 2026 within Technology SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Careview Communications Inc19.65%$ 19.648 millions
Solaredge Technologies Inc 19.63%$ 19.630 millions
Nixxy Inc 19.50%$ 19.501 millions
Multisensor Ai Holdings inc 19.45%$ 19.450 millions
Eastman Kodak Company19.39%$ 19.392 millions
Appfolio Inc 19.34%$ 19.335 millions
Par Technology Corporation19.12%$ 19.125 millions
Zw Data Action Technologies Inc 18.98%$ 18.978 millions
Pdf Solutions Inc18.95%$ 18.947 millions
Workiva Inc18.94%$ 18.936 millions
Snap Inc18.89%$ 18.890 millions
Electronic Arts Inc 18.85%$ 18.851 millions
Duolingo Inc 18.63%$ 18.631 millions
Backblaze Inc 18.51%$ 18.512 millions
Varonis Systems Inc 18.50%$ 18.503 millions
Pinterest Inc 18.17%$ 18.175 millions
Mitek Systems Inc 18.17%$ 18.170 millions
Waystar Holding Corp 18.11%$ 18.112 millions
Evertec Inc 18.11%$ 18.108 millions
Microsoft Corporation17.75%$ 17.747 millions
Benchmark Electronics Inc 17.69%$ 17.692 millions
Caci International Inc17.57%$ 17.573 millions
Marqeta Inc 17.02%$ 17.024 millions
Corning Inc16.65%$ 16.649 millions
A10 Networks Inc 16.63%$ 16.629 millions
Zoominfo Technologies Inc 16.60%$ 16.604 millions
Birchtech Corp 16.50%$ 16.495 millions
Carecloud Inc 16.45%$ 16.448 millions
Apple Inc 16.36%$ 16.357 millions
Alkami Technology Inc 16.33%$ 16.329 millions


About Neogenomics Inc Revenue Growth Rates (NEO), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Neogenomics Inc (CIK 1077183).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001077183-26-000059
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Neogenomics Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.